BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33301840)

  • 1. Non-coding RNAs and the mineralocorticoid receptor in the kidney.
    Butterworth MB
    Mol Cell Endocrinol; 2021 Feb; 521():111115. PubMed ID: 33301840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone-induced microRNAs act as feedback regulators of mineralocorticoid receptor signaling in kidney epithelia.
    Ozbaki-Yagan N; Liu X; Bodnar AJ; Ho J; Butterworth MB
    FASEB J; 2020 Sep; 34(9):11714-11728. PubMed ID: 32652691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Aldosterone Signaling by MicroRNAs.
    Butterworth MB; Alvarez de la Rosa D
    Vitam Horm; 2019; 109():69-103. PubMed ID: 30678867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microRNAs in aldosterone signaling.
    Butterworth MB
    Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):390-394. PubMed ID: 30074910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Context-dependent mechanisms modulating aldosterone signaling in the kidney.
    Shibata S
    Clin Exp Nephrol; 2016 Oct; 20(5):663-670. PubMed ID: 26846783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-19 is regulated by aldosterone in a sex-specific manner to alter kidney sodium transport.
    Farrell CE; Liu X; Yagan NO; Suda AC; Cerqueira DM; Bodnar AJ; Kashlan OB; Subramanya AR; Ho J; Butterworth MB
    Am J Physiol Cell Physiol; 2024 Jan; 326(1):C282-C293. PubMed ID: 38047299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-324-5p and miR-30c-2-3p Alter Renal Mineralocorticoid Receptor Signaling under Hypertonicity.
    Vu TA; Lema I; Hani I; Cheval L; Atger-Lallier L; Souvannarath V; Perrot J; Souvanheuane M; Marie Y; Fabrega S; Blanchard A; Bouligand J; Kamenickỷ P; Crambert G; Martinerie L; Lombès M; Viengchareun S
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A MicroRNA Cluster miR-23-24-27 Is Upregulated by Aldosterone in the Distal Kidney Nephron Where it Alters Sodium Transport.
    Liu X; Edinger RS; Klemens CA; Phua YL; Bodnar AJ; LaFramboise WA; Ho J; Butterworth MB
    J Cell Physiol; 2017 Jun; 232(6):1306-1317. PubMed ID: 27636893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs and the regulation of aldosterone signaling in the kidney.
    Butterworth MB
    Am J Physiol Cell Physiol; 2015 Apr; 308(7):C521-7. PubMed ID: 25673770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects of rapid aldosterone signaling.
    Grossmann C; Gekle M
    Mol Cell Endocrinol; 2009 Sep; 308(1-2):53-62. PubMed ID: 19549592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Nongenomic effects via the mineralocorticoid receptor.
    Ruhs S; Nolze A; Hübschmann R; Grossmann C
    J Endocrinol; 2017 Jul; 234(1):T107-T124. PubMed ID: 28348113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease.
    Hagiwara S; Gohda T; Kantharidis P; Okabe J; Murakoshi M; Suzuki Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone regulates microRNAs in the cortical collecting duct to alter sodium transport.
    Edinger RS; Coronnello C; Bodnar AJ; Labarca M; Bhalla V; LaFramboise WA; Benos PV; Ho J; Johnson JP; Butterworth MB
    J Am Soc Nephrol; 2014 Nov; 25(11):2445-57. PubMed ID: 24744440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-binding protein HuR enhances mineralocorticoid signaling in renal KC3AC1 cells under hypotonicity.
    Lema I; Amazit L; Lamribet K; Fagart J; Blanchard A; Lombès M; Cherradi N; Viengchareun S
    Cell Mol Life Sci; 2017 Dec; 74(24):4587-4597. PubMed ID: 28744670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone receptor antagonists: current perspectives and therapies.
    Guichard JL; Clark D; Calhoun DA; Ahmed MI
    Vasc Health Risk Manag; 2013; 9():321-31. PubMed ID: 23836977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Phosphatase 1α enhances renal aldosterone signaling via mineralocorticoid receptor stabilization.
    Nagarajan S; Vohra T; Loffing J; Faresse N
    Mol Cell Endocrinol; 2017 Jul; 450():74-82. PubMed ID: 28454724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid receptor actions in cardiovascular development and disease.
    Young MJ; Clyne CD
    Essays Biochem; 2021 Dec; 65(6):901-911. PubMed ID: 34414409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome.
    Nagase M
    Clin Exp Nephrol; 2010 Aug; 14(4):303-14. PubMed ID: 20533072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation.
    Gros R; Ding Q; Liu B; Chorazyczewski J; Feldman RD
    Am J Physiol Cell Physiol; 2013 Mar; 304(6):C532-40. PubMed ID: 23283935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.